ContactCredit ReportFinancialsPeopleOwnershipLatest ActivityMutual CompaniesDocumentsRepayment History

Orchard Therapeutics (Europe) Limited

Orchard Therapeutics (Europe) Limited is an active company incorporated on 2 September 2015 with the registered office located in London, Greater London. Orchard Therapeutics (Europe) Limited was registered 10 years ago.
Status
Active
Active since incorporation
Company No
09759506
Private limited company
Age
10 years
Incorporated 2 September 2015
Size
Medium
Turnover is under £54M
Under 250 employees
Confirmation
Submitted
Dated 14 February 2025 (8 months ago)
Next confirmation dated 14 February 2026
Due by 28 February 2026 (3 months remaining)
Last change occurred 8 months ago
Accounts
Submitted
For period 1 Jan31 Dec 2024 (1 year)
Accounts type is Full
Next accounts for period 31 December 2025
Due by 30 September 2026 (10 months remaining)
Address
245 Hammersmith Road
3rd Floor
London
W6 8PW
England
Address changed on 29 Aug 2022 (3 years ago)
Previous address was , 108 Cannon Street, London, EC4N 6EU
Telephone
020 38088286
Email
Available in Endole App
People
Officers
6
Shareholders
1
Controllers (PSC)
1
Director • British • Lives in UK • Born in Nov 1963
Director • British • Lives in Japan • Born in May 1967
Director • Japanese • Lives in Japan • Born in May 1964
Director • British • Lives in UK • Born in Mar 1967
Director • Japanese • Lives in Japan • Born in Nov 1961
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
Mutual Companies
Orchard Therapeutics Limited
Dr Hubert Baburaj Gaspar is a mutual person.
Active
Brands
Orchard Therapeutics
Orchard Therapeutics is a biotechnology company that develops gene therapies for patients with severe genetic diseases.
Financials
Net Assets, Total Assets & Total Liabilities (2016–2024)
Period Ended
31 Dec 2024
For period 31 Dec31 Dec 2024
Traded for 12 months
Cash in Bank
£6.9M
Decreased by £1.9M (-22%)
Turnover
£26.36M
Increased by £10.56M (+67%)
Employees
107
Increased by 3 (+3%)
Total Assets
£147.5M
Increased by £81.7M (+124%)
Total Liabilities
-£210.61M
Increased by £99.97M (+90%)
Net Assets
-£63.11M
Decreased by £18.27M (+41%)
Debt Ratio (%)
143%
Decreased by 25.36% (-15%)
Latest Activity
Full Accounts Submitted
10 Days Ago on 29 Oct 2025
Dr Jonathan Henry Welbore Ellis Appointed
1 Month Ago on 10 Sep 2025
Takeyoshi Yamashita Appointed
1 Month Ago on 10 Sep 2025
Abdul Hafeez Mullick Appointed
1 Month Ago on 10 Sep 2025
Yasuo Fujii Appointed
1 Month Ago on 10 Sep 2025
Confirmation Submitted
8 Months Ago on 20 Feb 2025
Full Accounts Submitted
1 Year 1 Month Ago on 7 Oct 2024
Orchard Therapeutics Plc (PSC) Details Changed
1 Year 4 Months Ago on 19 Jun 2024
Confirmation Submitted
1 Year 8 Months Ago on 26 Feb 2024
Subsidiary Accounts Submitted
2 Years 3 Months Ago on 2 Aug 2023
Get Credit Report
Discover Orchard Therapeutics (Europe) Limited's Credit Score, how much credit you can offer them, and how likely they are to repay you
Documents
Full accounts made up to 31 December 2024
Submitted on 29 Oct 2025
Appointment of Takeyoshi Yamashita as a director on 10 September 2025
Submitted on 25 Sep 2025
Appointment of Abdul Hafeez Mullick as a director on 10 September 2025
Submitted on 25 Sep 2025
Appointment of Yasuo Fujii as a director on 10 September 2025
Submitted on 25 Sep 2025
Appointment of Dr Jonathan Henry Welbore Ellis as a director on 10 September 2025
Submitted on 25 Sep 2025
Confirmation statement made on 14 February 2025 with updates
Submitted on 20 Feb 2025
Change of details for Orchard Therapeutics Plc as a person with significant control on 19 June 2024
Submitted on 20 Feb 2025
Full accounts made up to 31 December 2023
Submitted on 7 Oct 2024
Confirmation statement made on 14 February 2024 with updates
Submitted on 26 Feb 2024
Statement of capital following an allotment of shares on 31 January 2024
Submitted on 26 Feb 2024
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year